Joshua Krasnow, MD
Interventional Cardiology · Exeter, NHNPI 1114986205
Payments from drug & device makers
Across 400 payments — averaging $2258.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$767K
- Abbott$133K
- Pfizer$496
- Johnson & Johnson$470
- AstraZeneca$411
- Novartis$347
- plus $2K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 53 | $766,596 |
| Abbott | 135 | $133,008 |
| Pfizer | 22 | $496 |
| Johnson & Johnson | 31 | $470 |
| AstraZeneca | 28 | $411 |
| Novartis | 16 | $347 |
| Amgen | 20 | $326 |
| E.r. Squibb & Sons, L.L.C. | 16 | $284 |
| Gilead | 15 | $182 |
| Stryker | 1 | $176 |
| Novo Nordisk | 8 | $132 |
| Boston Scientific | 5 | $116 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Boehringer Ingelheim | 6 | $104 |
| Cardiovascular Systems Inc. | 9 | $103 |
| Merck | 5 | $93 |
| Regeneron Healthcare Solutions, Inc. | 6 | $85 |
| Sanofi-aventis U.S. LLC | 4 | $68 |
| Penumbra, Inc. | 2 | $64 |
| CMP Pharma, Inc. | 2 | $50 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| Bayer | 2 | $33 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Philips North America LLC | 1 | $15 |
| Chiesi USA, Inc. | 1 | $12 |
| Abiomed | 1 | $11 |
How this compares
$903,406 in reported general payments places this provider in the 95th percentile of 26 interventional cardiology providers in New Hampshire.
See all interventional cardiology providers in New Hampshire →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Exeter
- Lazaro DiazExeter$15K
- Jessica SutherlandExeter$2K
- James DevriesLebanon$578K
- Aaron KaplanLebanon$218K
- Xiaoyu Yang-GiulianoManchester$43K
- Shahab MoossaviConcord$36K
- Alina RobertLebanon$26K
- Nitish SharmaDover$23K
- Rodrigo Mendirichaga MaganaDover$21K
- Paul BoffettiNashua$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.